Madrigal Pharma director John C. Reed files initial beneficial ownership statement
MDGL•Form 3 filing
- Madrigal Pharmaceuticals director John C. Reed filed an initial Form 3 with the SEC dated Aug. 11, 2026.
Related News
Profusa announces special shareholder meeting
PFSA•
Virtu Financial director John Nixon disposes of 9,094 shares worth $546,822.22
VIRT•
AbbVie EVP, Chief Business and Strategy Officer Nicholas Donoghoe disposes of 32,710 common shares worth $8.18 million
ABBV•
AI storage firm Backblaze drops after unveiling $150 mln convertible deal
BLZE•
Allspring Income Opportunities Fund declares USD 0.05 monthly distribution
EAD•